Emirates Oncology Society, Novartis Launch New Partnership to Transform Breast Cancer Care in the UAE

‘United for Breast Cancer – A Commitment for Excellence and Innovation’ aims to address critical areas in breast cancer diagnosis, management, patient journeys, and local data generation.

30 October 2023; Dubai, United Arab Emirates — Novartis, a focused, innovative medicines company, and the Emirates Oncology Society (EOS) announced this week the launch of their partnership for United for Breast Cancer – A Commitment for Excellence and Innovation. The pioneering partnership aims to transform the landscape of breast cancer care in the UAE and generate local data to enhance the treatment and care of breast cancer patients across the emirates.

Breast cancer is the most common cancer in the world and in the Gulf, with the average age of diagnosis in the UAE being around 10 years younger than in Western countries.

Continue reading Emirates Oncology Society, Novartis Launch New Partnership to Transform Breast Cancer Care in the UAE →